Global Sexual Enhancement Supplements Market to Reach $608.9 Million by 2027
Amid the COVID-19 crisis, the global market for Sexual Enhancement Supplements estimated at US$300 Million in the year 2020, is projected to reach a revised size of US$608.9 Million by 2027, growing at aCAGR of 10.6% over the period 2020-2027. Online Stores, one of the segments analyzed in the report, is projected to record 11.3% CAGR and reach US$429.5 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Retail Outlets & Specialty Stores segment is readjusted to a revised 9.2% CAGR for the next 7-year period.
The U.S. Market is Estimated at $81 Million, While China is Forecast to Grow at 14.1% CAGR
The Sexual Enhancement Supplements market in the U.S. is estimated at US$81 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$131.5 Million by the year 2027 trailing a CAGR of 14.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7.3% and 9.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 8.3% CAGR.We bring years of research experience to this 7th edition of our report. The 174-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.Competitors identified in this market include, among others,
- Ansell Ltd.
- Doc Johnson Enterprises
- Innovus Pharmaceuticals Inc.
- Leading Edge Health
- Lovehoney Group Ltd.
- Pound International Corporation
- Reckitt Benckiser Group PLC